Emily Scott

Primary office:
Malott Hall, room 4067

Dr. Emily Scott is a professor in the Department of Medicinal Chemistry. Her research focuses on understanding how individual human cytochrome P450 (CYP) enzymes perform roles in drug metabolism and physiologically important endogenous processes.  Interest in the basic biochemistry and structural biology of these intriguing membrane enzymes overlaps with application of this knowledge to benefit human health and disease treatment.  CYP2A enzymes are involved in activation of tobacco procarcinogens into DNA-modifying agents, so inhibitors are of interest for their potential to prevent lung cancer.  CYP17A1 is essential in production of steroid hormones that drive prostate cancer proliferation.  Interactions of CYPs with their substrates and existing and new inhibitors are probed using a variety of biochemical and structural biology techniques.

Doctoral Program Profiles

The University of Kansas is a major public research and teaching institution with a number of doctoral degree programs. Visit the profiles page which provides summary data for Lawrence-campus doctoral programs as one-page doctoral program profiles.

One of 34 U.S. public institutions in the prestigious Association of American Universities
26 prestigious Rhodes Scholars — more than all other Kansas colleges combined
Nearly $290 million in financial aid annually
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
23rd nationwide for service to veterans —"Best for Vets," Military Times
KU Today